Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery
Clinical trial NCT03522259 · COMPLETED
Trial details
- NCT number
- NCT03522259
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-19
- Primary completion
- 2023-12-31
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.